Document ID: chunk:federal_register_of_legislation:F2024C00867:reg:7
Version: federal_register_of_legislation:F2024C00867
Segment Type: reg
Provision Reference: reg 7
Character Range: 32194–33732

7                                                           the fill volume in mL

 (2) The information required by subsection (1) must:
           (a) be orientated in the same direction; and
           (b) for the information mentioned in items 1 to 3—be displayed in a text size of at least 3 mm; and
           (c) for all other text—be displayed in a text size of at least 1.5 mm.
 (3) The name of the good on the main label must be presented in a continuous, uninterrupted manner and not be broken up by additional words or images.
 (4) Where a therapeutic vaping substance or a therapeutic vaping substance accessory contains nicotine, the name of the good, the word "nicotine" and the concentration of nicotine must:
           (a) appear as a cohesive unit by placing the word "nicotine" and the concentration of nicotine together in a single line of text immediately below the name of the good; and
           (b) not be separated by additional words or images.
 (5) Where a therapeutic vaping substance or a therapeutic vaping substance accessory does not contain nicotine, the name of the good and concentration of nicotine must:
           (a) appear as a cohesive unit by placing the words "nicotine 0 mg/mL" immediately below the name of the good; and
           (b) not be separated by additional words or images.
 (6) Where a therapeutic vaping substance or a therapeutic vaping substance accessory contains nicotine, the main label on the primary pack must contain a warning statement panel as specified in section 20.